Related by context. Frequent words. (Click for all words.) 66 secondary endpoints 65 primary efficacy endpoint 64 secondary endpoint 64 primary endpoint 64 primary endpoints 63 statistically significant improvement 61 placebo 61 mg BID 61 placebo p 59 placebo p = 58 p = #.# [004] 58 evaluable 58 p = #.# [002] 58 tiotropium 58 statistically significant 57 pharmacodynamic 57 clinically meaningful 57 mg dose 56 placebo controlled 56 P = .# 56 tolerability 56 evaluable patients 56 statistically significant reduction 55 adalimumab 55 symptom severity 55 ACR# [002] 55 ACTEMRA 55 efficacy endpoints 54 free survival PFS 54 p = 54 Efficacy 54 randomized 54 treatment emergent adverse 54 RG# [001] 54 FOLFOX 54 pramipexole 53 LEVADEX 53 certolizumab pegol 53 FEV1 53 randomized double 53 statistically significant differences 53 etanercept 53 insulin glargine 53 Phase 2a 53 tolerability profile 53 randomized placebo controlled 53 n = 53 pharmacokinetics 53 Phase 2a clinical 53 pharmacokinetic 52 plus ribavirin 52 aripiprazole 52 reach statistical significance 52 mg doses 52 valsartan 52 pharmacokinetic profile 52 Phase 1b 52 docetaxel 52 mg kg 52 monotherapy 52 Phase 2b study 52 LVEF 52 sitagliptin 51 double blind placebo 51 Azixa 51 HbA1c levels 51 administered orally 51 Phase IIa clinical 51 antiviral activity 51 sunitinib 51 citalopram 51 dexamethasone 51 HCV RNA 51 glimepiride 51 Phase 2b clinical 51 clinically relevant 50 bortezomib 50 multiple ascending dose 50 pharmacodynamics 50 pravastatin 50 Phase IIb clinical 50 viral load 50 non inferiority 50 Phase IIa 50 plasma concentrations 50 blind randomized 50 pioglitazone 50 telbivudine 50 zoledronic acid 50 ≥ 50 dosed 49 discontinuations 49 quetiapine 49 AZD# 49 infliximab 49 raltegravir 49 HbA1c 49 telmisartan 49 IDX# 49 nasopharyngitis 49 copies mL